In the News May 28, 2019

The Deal | OncoSec Raises Capital to Fuel Clinical Trials

Alston & Bird is noted for representing OncoSec Medical Inc. in its $11 million initial public offering.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.